Company & Sponsor Intelligence

Technische Universität Dresden

Evidence-linked intelligence derived from the current NeuroRisk clinical research corpus. Coverage reflects indexed source data and is not a claim of complete company activity.

Request enterprise analysis →

Indexed trials3

Recruiting0

Completed2

Countries1

Therapeutic footprint

parkinsonssubstance_use

Indexed studies

NCT00180037Coenzyme Q10 as a Symptomatic Treatment in Parkinson's Disease
parkinsons · GermanyPHASE3

NCT01858818Project 4: Acute Effects of Alcohol on Learning and Habitization in Healthy Young Adults
substance_use · GermanyCOMPLETED

NCT02275884Pharmacologically Active Constituents of Chocolate and Their Symptomatic Effects in Patients With Idiopathic Parkinson's Disease
parkinsons · GermanyNA

Intelligence layer updated: 2026-10-29 06:17:44.639239+00:00

Enterprise intelligence

Compare sponsor activity, recruiting momentum, therapeutic exposure, geography and connected research signals across the neuroscience ecosystem.

Request comparative intelligence →